Show Notes
A dairy cow is worth $1,000 to $2,000 to a farmer, whereas a broiler chicken, raised for meat, generates just $4 of profit. Quantifying animals this way may feel uncomfortable, but those $4 are all a farmer can spend to keep a chicken healthy. And this places some really interesting constraints on how biotechnology must be scaled (in terms of vaccines and other interventions) in the animal welfare space.
In this episode, Robert Yaman, CEO of Innovate Animal Ag, argues that the way to improve animal welfare is to make farming more efficient rather than less. We discuss in-ovo sexing (which uses PCR or hyperspectral imaging to identify an egg's sex before it hatches, and which could help end the culling of 300 million male chicks a year); why hyperspectral cameras work on brown eggs but not white ones; and electron-beam vaccines, which shred a bacterium's DNA while leaving its surface proteins intact, thus producing a farm-specific vaccine for less than one penny per dose.
Robert also reveals publicly, for the first time, that Innovate Animal Ag is building an "accelerator farm": a commercial broiler facility that doubles as a testbed where startups can trial new technology in an industry that hasn't changed all that much in the last fifty years.
Chapters 0:00 Why animal welfare needs scalable technologies 6:40 How chickens were bred for meat and eggs 12:43 Does farm efficiency improve animal welfare overall? 23:41 How the poultry supply chain works, from hatchery to farm 32:01 In ovo sexing to prevent chick culling 47:12 Electron beams and vaccines 1:01:04 Ozempic for chickens 1:15:30 Precision farming and the Accelerator Farm
More from The New Biology
Nick Desnoyer, a plant biologist in Norwich, England, is designing and creating flowers that don’t exist anywhere in nature. In this interview, he reveals his next project: Paintunia, a petunia that acts as a living canvas. These petunias have an inducible gene; when you lightly touch a bud (before it opens) with a clear molecule, called dexamethasone, that molecules seeps into cells, switches on the gene, and causes them to make a pigment. The result is a paintable flower, where molecules are literally used to control which colors show up in which places. For a prior project, Nick turned Arabidopsis, a small (and quite ugly) plant widely used in research, into little pink “micro-roses.”
Pioneer Labs, a nonprofit research group, has engineered a microbe that eats Martian dirt and excretes bioplastic. It is the first step of their "five organism" plan to terraform Mars and make the planet habitable. This interview is with Erika DeBenedictis, the co-founder and CEO of Pioneer Labs. Subscribe to Asimov Press: https://press.asimov.com 0:00 A first microbe engineered for Mars 5:03 Simulating Martian chemistry 8:27 The five "pioneer species" 17:20 Water, warming, and nitrogen 26:39 Radiation, growth rates, and poor measurements 35:49 Starship 41:05 Why create a second biosphere?
Chemists at the University of Minnesota, led by Kate Adamala, recently built a synthetic cell that eats, grows, and divides; purely by putting together molecules in the laboratory. Their creation, called SpudCell, can only divide for five generations. What will it take to make it grow for longer? And why bother making a synthetic cell in the first place? Subscribe to Asimov Press: https://press.asimov.com Chapters: 00:00 SpudCell is not alive 05:16 How SpudCell was made 13:14 How to make a continuously replicating cell 29:48 Finding new mechanisms for cell division 40:38 What is the point of SpudCell? 54:51 Mirror life, and whether SpudCell uniquely enables it 1:14:38 Biotic, China, and 2050
Scientists have studied bacteria under microscopes for 400 years. But Yonatan Chemla, a postdoctoral fellow at MIT, has developed a technology that lets us see microbes from a drone 100 meters in the air. In this episode, we discuss the emerging field of "hyperspectral biology," which uses hyperspectral cameras (first built by NASA in the 1980s) to detect molecules with unique light-absorption signatures. With this technology, you could engineer a microbe to sense a landmine, for example, and release a pigment in response. A drone could then spot that pigment from hundreds of meters away. By spraying other types of engineered microbes over a field, they could map heavy metals, report on soil health, or find gold deposits. But almost none of this can happen in the United States. The EPA regulates engineered microbes as chemicals under the Toxic Substances Control Act, a 1976 law that never mentions biology, and the agency seems to have approved just one product through it. As a result, many of biotechnology's most useful ideas — microbes that break down plastic, sense landmines, or remove pollution from water — never leave the laboratory. Chapters: [00:00:00] Introduction [00:04:08] Applications for hyperspectral biology [00:07:33] How to build a biosensor [00:13:00] Molecular absorption data [00:22:12] How hyperspectral cameras work [00:38:15] Spatial resolution and satellite monitoring [00:51:04] Regulations around environmental release [01:08:44] Risk vs progress Further Reading: Summary of the Toxic Substances Control Act, EPA: https://www.epa.gov/laws-regulations/summary-toxic-substances-control-act Design and regulation of engineered bacteria for environmental release, Nature Microbiology: https://www.nature.com/articles/s41564-024-01918-0 Hyperspectral reporters for long-distance and wide-area detection of gene expression in living bacteria, Nature Biotechnology: https://www.nature.com/articles/s41587-025-02622-y Seeing microbes from the sky, Asimov Press: https://press.asimov.com/articles/hyperspectral
Markov Biosciences, a startup in San Francisco, is betting that biology is about to have its GPT moment. In this episode, founder Adam Green explains the "bitter lesson" for biology, the idea borrowed from Richard Sutton that large unbiased datasets and the right training objective tend to outcompete models with hard-coded rules and human priors. Adam thinks, in particular, that the virtual cell field took a wrong turn by spending hundreds of millions of dollars collecting expensive perturbation data. Green’s counterargument is that the data needed to train useful virtual cells is not limiting, but rather compute (and the loss function) are. By treating single-cell RNA-seq as a ranking problem rather than raw counts (a century-old idea traceable to a 1927 psychophysics paper), they found that virtual cells pre-trained on plain observational data show clean scaling laws, getting monotonically better at predicting unseen perturbations as the models grow, and beating a state-of-the-art model built specifically for that task.